Cancer News and Research RSS Feed - Cancer News and Research Twitter

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Most cancers are named for where they start. For example, lung cancer starts in the lung, and breast cancer starts in the breast. The spread of cancer from one part of the body to another is called metastasis. Symptoms and treatment depend on the cancer type and how advanced it is. Treatment plans may include surgery, radiation and/or chemotherapy.
UAB offers MRI-US image fusion technique for prostate cancer detection

UAB offers MRI-US image fusion technique for prostate cancer detection

The latest advancement in prostate cancer detection is magnetic resonance imaging and ultrasound fusion-guided biopsy, which offers benefits for both patient and physician. [More]
Rates of type 1 diabetes increase significantly among non-Hispanic white youth

Rates of type 1 diabetes increase significantly among non-Hispanic white youth

The rate of non-Hispanic white youth diagnosed with type 1 diabetes increased significantly from 2002 to 2009 in all but the youngest age group of children, according to a new study published today in the journal Diabetes. [More]
Study reveals subtypes, potential diagnostic and treatment clues for papillary thyroid carcinomas

Study reveals subtypes, potential diagnostic and treatment clues for papillary thyroid carcinomas

A comprehensive analysis of the genomes of nearly 500 papillary thyroid carcinomas (PTC) – the most common form of thyroid cancer – has provided new insights into the roles of frequently mutated cancer genes and other genomic alterations that drive disease development. [More]
UC San Diego Sanford Stem Cell Clinical Center named new 'alpha clinic'

UC San Diego Sanford Stem Cell Clinical Center named new 'alpha clinic'

In a push to further speed clinical development of emerging stem cell therapies, Sanford Stem Cell Clinical Center at UC San Diego Health System was named today one of three new "alpha clinics" by the California Institute for Regenerative Medicine, the state's stem cell agency. [More]
Research could pave way for more effective drugs to treat inflammation

Research could pave way for more effective drugs to treat inflammation

Six Case Western Reserve scientists are part of an international team that has discovered two compounds that show promise in decreasing inflammation associated with diseases such as ulcerative colitis, arthritis and multiple sclerosis. [More]
Duke researchers develop new collaborative cancer care model for patients

Duke researchers develop new collaborative cancer care model for patients

Doctors at Duke University Hospital have developed a new collaborative model in cancer care that reduced the rates at which patients were sent to intensive care or readmitted to the hospital after discharge. [More]
Research finds link between autism spectrum disorder and air toxics

Research finds link between autism spectrum disorder and air toxics

Children with autism spectrum disorder (ASD) were more likely to have been exposed to higher levels of certain air toxics during their mothers' pregnancies and the first two years of life compared to children without the condition, according to the preliminary findings of a University of Pittsburgh Graduate School of Public Health investigation of children in southwestern Pennsylvania. [More]
Researchers reveal how particular melanoma cells help tumors resist drugs

Researchers reveal how particular melanoma cells help tumors resist drugs

UNC School of Medicine researchers have pinpointed a set of intriguing characteristics in a previously unknown subpopulation of melanoma cancer cells in blood vessels of tumors. These cells, which mimic non-cancerous endothelial cells that normally populate blood vessels in tumors, could provide researchers with another target for cancer therapies. [More]
BRI receives FDA permission to conduct study of Antineoplastons A10 and AS2-1 in DIPG patients

BRI receives FDA permission to conduct study of Antineoplastons A10 and AS2-1 in DIPG patients

Burzynski Research Institute, Inc. announced today that the U.S. Food and Drug Administration has given the company permission to conduct an open-label study of Antineoplastons A10 and AS2-1 in patients > 3 months of age with a diffuse intrinsic brainstem glioma (DIPG). [More]
Oncolytics signs equity distribution agreement with Canaccord Genuity

Oncolytics signs equity distribution agreement with Canaccord Genuity

Oncolytics Biotech Inc. announced today that it has entered into an "at-the-market" (ATM) equity distribution agreement with Canaccord Genuity Inc. acting as sole agent. [More]
Experimental drug may help fight cervical cancer

Experimental drug may help fight cervical cancer

University of Leicester academic leads study into effects of cediranib drug in chemotherapy treatment of cervical cancer. [More]
Medicinal plant market goes untested for health hazards, shows study

Medicinal plant market goes untested for health hazards, shows study

Medicinal plant market goes untested for health hazards, according to a recent study published in journal Fungal Biology [More]
Research shows FGF21 hormone acts directly on brain to regulate obesity

Research shows FGF21 hormone acts directly on brain to regulate obesity

A hormone seen as a popular target to develop weight-loss drugs works by directly targeting the brain and triggering previously unknown activity in the nervous system, UT Southwestern Medical Center obesity researchers have found. [More]
Viewpoints: Fund CHIP; media overdrive on Ebola; slowdown in Medicare costs

Viewpoints: Fund CHIP; media overdrive on Ebola; slowdown in Medicare costs

In what may be a hopelessly quixotic effort, supporters of the federal Children's Health Insurance Program are trying to persuade Congress to renew its funding almost a year in advance -; and in a lame-duck session. Nevertheless, lawmakers ought to heed that call. The program plugs a troubling gap between Medicaid and the Affordable Care Act's subsidized plans, and states need to know whether they can count on federal funding or whether they will have to spend far more dollars of their own (10/21). [More]
MIT researchers develop new way to model effects of cancer-causing genetic mutations

MIT researchers develop new way to model effects of cancer-causing genetic mutations

Sequencing the genomes of tumor cells has revealed thousands of genetic mutations linked with cancer. However, sifting through this deluge of information to figure out which of these mutations actually drive cancer growth has proven to be a tedious, time-consuming process. [More]
French hospital uses Sophia DDM Platform to improve diagnostic testing of congenital disorders

French hospital uses Sophia DDM Platform to improve diagnostic testing of congenital disorders

The Hospices Civils de Lyon, the second-largest University Hospital Network in France, has elected to use the Sophia Genetics Data Driven Medicine (DDM) Platform to support improvements in diagnostic testing for patients suffering from congenital disorders. [More]
The PROBEAT-RT Proton Beam Therapy System incorporating real-time tumor-tracking is approved in Japan

The PROBEAT-RT Proton Beam Therapy System incorporating real-time tumor-tracking is approved in Japan

Hokkaido University and Hitachi, Ltd. have announced that the approval under Japan’s Pharmaceutical Affairs Law has been granted to Hitachi for the manufacture and sales of the PROBEAT-RT, a proton beam therapy treatment system combining spot scanning irradiation and Real-time Tumor-tracking Radiation Therapy. [More]
Helping children understand Ebola

Helping children understand Ebola

It dominates the headlines and is striking fear and panic in many communities around the world, Ebola. The constant barrage of information and so much unknown can be especially difficult for children, making it all the more important for parents to help their kids feel safe and to have a dialogue with them at the appropriate developmental level. [More]
UH's Neurological Institute designated as Gold Center of Excellence

UH's Neurological Institute designated as Gold Center of Excellence

The Neurological Institute at University Hospitals has been designated as a Gold Center of Excellence (COE) and featured as a top performing center by NeuStrategy, Inc., a Chicago consulting firm providing strategic support to neuroscience, oncology and orthopaedic service providers. [More]
Afatinib active against NSCLC nervous system metastases

Afatinib active against NSCLC nervous system metastases

Heavily pretreated patients with epidermal growth factor receptor-mutated non-small-cell lung cancer and central nervous system metastases may benefit from treatment with afatinib, say German researchers. [More]